Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids
- 23 May 2019
- journal article
- research article
- Published by Elsevier BV in Cell Stem Cell
- Vol. 24 (6), 927-943.e6
- https://doi.org/10.1016/j.stem.2019.04.017
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Occupying Chromatin: Polycomb Mechanisms for Getting to Genomic Targets, Stopping Transcriptional Traffic, and Staying PutMolecular Cell, 2013
- PCGF Homologs, CBX Proteins, and RYBP Define Functionally Distinct PRC1 Family ComplexesMolecular Cell, 2012
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- Epithelial cell polarity: a major gatekeeper against cancer?Cell Death & Differentiation, 2011
- An Emerging Model for BAP1’s Role in Regulating Cell Cycle ProgressionCell Biochemistry and Biophysics, 2011
- The Polycomb complex PRC2 and its mark in lifeNature, 2011
- Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUBNature, 2010
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatmentJournal of Hepatology, 2008
- Role of histone H2A ubiquitination in Polycomb silencingNature, 2004